Long-term side effects, the expense of medications, and the difficulty of taking medications
continuously for long periods of time are all problems with complicated anti-HIV drug
regimens. The purpose of this study is to determine whether two drugs, atazanavir (ATV) and
ritonavir (RTV), will control HIV infection when taken together without any other anti-HIV
drugs after 48 weeks of viral suppression.
Hypothesis: Simplified maintenance therapy with ATV and RTV alone after virologic suppression
does not markedly increase the risk of virologic failure.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)